Tramadol

Tramadol is a prescription opioid used for moderate pain. It is often perceived as 'weaker' or safer than other opioids, but that perception is misleading: tramadol carries the standard opioid risks of dependence and respiratory depression, and it adds two dangers many other opioids don't — a lowered seizure threshold and the potential for serotonin syndrome, because tramadol also affects serotonin and norepinephrine signaling. It is widely prescribed, widely misused in some regions, and, like other opioids, can be fatal in overdose or when combined with other depressants. Its dual action makes its risk profile more complicated than its 'mild opioid' reputation suggests.

Tramadol has a dual mechanism. Part of its effect comes from acting (itself and through an active metabolite) on mu-opioid receptors to relieve pain, with the same class consequences of sedation, euphoria-driven reinforcement, and suppression of breathing. The other part comes from inhibiting the reuptake of serotonin and norepinephrine — similar to some antidepressants — which contributes to pain relief but also explains its distinctive added risks: it can lower the seizure threshold (making seizures more likely, especially at high doses or in combination with certain drugs) and can contribute to serotonin syndrome when combined with other serotonergic medications. As with other opioids, repeated use produces tolerance and physical dependence.

At usual doses tramadol relieves pain and commonly causes drowsiness, dizziness, nausea, constipation, dry mouth, and sometimes a sense of calm or mild euphoria. Higher doses bring stronger sedation and the opioid danger of slowed breathing, and tramadol specifically raises the risk of seizures — which can occur even at prescribed doses in susceptible people and become more likely at high doses. Combining it with serotonergic drugs can produce serotonin syndrome (agitation, rapid heart rate, high temperature, muscle rigidity, confusion). With repeated use, tolerance and physical dependence develop, and stopping can produce both a typical opioid withdrawal and, for some, atypical withdrawal symptoms.

Tramadol carries the core opioid risk of respiratory depression — worsened by higher doses, reduced tolerance, and combination with other depressants such as alcohol, benzodiazepines, or other opioids — plus two added dangers: seizures (it lowers the seizure threshold, a risk in overdose and in people with seizure risk factors) and serotonin syndrome when combined with other serotonergic drugs (including many antidepressants), which can be life-threatening. Overdose can involve slowed or stopped breathing, seizures, and unconsciousness. Naloxone (Narcan) reverses the opioid component of a tramadol overdose, is available over the counter in the U.S. since 2023, and is safe to give even if opioids aren't the cause — but because tramadol also causes seizures, emergency care is still essential; give naloxone if available and call 911. Anything sold as tramadol outside a pharmacy carries the illicit-supply risk of contamination with stronger opioids such as fentanyl. For poisoning guidance call Poison Control at 1-800-222-1222; for substance-use support the SAMHSA National Helpline is 1-800-662-4357.